F. Y. Ahmed

Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors (1999)

Ahmed, F.Y., Johnston, S.J., Cassidy, J., Kelly, T. O', Binnie, N., Murray, G.I., ...

A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma.

Ahmed, F. Y., Leonard, G. A., A'Hern, R., Taylor, A. E., Lorentzos, A., Atkinson, H., ...

We have examined the efficacy, toxicity and host immunological response of two different dose schedules of interleukin 2 (IL-2) given subcutaneously, daily for 3 months in patients with renal cell...

A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site

Macdonald, A G, Nicolson, M C, Samuel, L M, Hutcheon, A W, Ahmed, F Y

Carcinoma of unknown primary site remains a common clinical diagnosis, accounting for between 5 and 10% of all cancer patients. Numerous combination chemotherapy regimens have been used in the...